SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (358)8/4/2004 6:39:17 AM
From: JFitnich   of 590
 
Wilder,

That's kind of what I was afraid of. I was looking at best case for the drug - if everything flies right. An extremely dangerous assumption in biotech.

If the best case doesn't fly, I usually head for the hills. It's a shame. They had a shot with the IMCL debacle to get close. I guess the IMNX / AMGN merger didn't help things.

I just don't see where AMGN is going to put a lot of push behind a $300MM product where they only get half and have to kick back for manufacturing costs.

Thanks for your comments.

JF
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News